Rhumbline Advisers »

Concert Pharma Sun Pharmaceutical Cvr shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Concert Pharma Sun Pharmaceutical Cvr shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Concert Pharma Sun Pharmaceutical Cvr

Tip: Access up to 7 years of quarterly data

All positions including Concert Pharma Sun Pharmaceutical Cvr held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Concert Pharma Sun Pharmaceutical Cvr by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-06-30 $0 799 0.00
2024-03-31 $0 799 0.00
2023-12-31 $0 799 0.00
2023-09-30 $0 799 0.00
2023-06-30 $0 799 0.00

More positions owned by Rhumbline Advisers

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Facebook Inc cl a (META)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Berkshire Hathaway (BRK.B)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Exxon Mobil Corporation (XOM)
Visa (V)
UnitedHealth (UNH)

View all positions for Rhumbline Advisers

Top funds holding Concert Pharma Sun Pharmaceutical Cvr

Rhumbline Advisers

View all funds holding Concert Pharma Sun Pharmaceutical Cvr